VistaGen Therapeutics
VTGN
VTGN
28 hedge funds and large institutions have $2.39M invested in VistaGen Therapeutics in 2020 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 7 increasing their positions, 2 reducing their positions, and 2 closing their positions.
Holders
28
Holders Change
+3
Holders Change %
+12%
% of All Funds
0.57%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
7
Reduced
2
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Vanguard Group
Malvern,
Pennsylvania
|
$1.36M |
| 2 |
2
Goldman Sachs
New York
|
$99K |
| 3 |
3
Renaissance Technologies
New York
|
$86K |
| 4 |
4
Two Sigma Advisers
New York
|
$20K |
| 5 |
5
Northern Trust
Chicago,
Illinois
|
$74K |
Top Sellers
| 1 |
1
UBS Group
Zurich,
Switzerland
|
$14K |
| 2 |
2
Jane Street
New York
|
$0 |
| 3 |
SCM
3
Sitrin Capital Management
Century City,
California
|
$0 |
| 4 |
DADC
4
D.A. Davidson & Co
Great Falls,
Montana
|
$96K |
